Media Coverage

Crain's Chicago Business 0

Five years ago, Dr. Elizabeth McNally was working in her University of Chicago lab when she received a call from a parent whose sons are afflicted with the rare form of muscular dystrophy she studies. Exon-skipping gene therapy worked for other forms of the disease, but every scientist the parent approached had told him it wouldn’t work for this one. McNally hesitated, too, but agreed to study it. “Why not?” she recalls. “No one had proved it can’t be done.”

U.S. News & World Report 0

The drug levodopa is a leading treatment for Parkinson’s disease, but for most patients the medication also brings debilitating side effects. Now, scientists say animal studies are pointing to a compound that might reduce those unwanted effects. “If clinical trials confirm our preliminary findings, the eventual drug developed could make a significant improvement in the quality of life for people with Parkinson’s disease,” lead researcher D. James Surmeier, chair of physiology at Northwestern University School of Medicine in Chicago, said in a university news release.


Dr. Donald Lloyd-Jones of Northwestern University in Chicago, who was not involved in the study, welcomed the news. “This is a game-changer for many, but not all,” he told NBC News. He said he’ll look at working harder to get blood pressure lower in his healthy patients over 50.

Associated Press 0

Fat that builds around the abdominal organs is particularly linked to diabetes, heart disease and other metabolic abnormalities than fat that lies under the skin, said obesity expert Dr. Lisa Neff of Northwestern University, who wasn’t involved the study. Genetics plays a role in apple shapes and waistlines tend to increase with age, so Neff advised even normal-weight people to pay attention if belts are getting tighter.